| Literature DB >> 19384281 |
Milan Mladenović1, Nenad Vuković, Neda Nićiforović, Slobodan Sukdolak, Slavica Solujić.
Abstract
Several novel 4-hydroxy-chromene-2-one derivatives 2b-16b were easily prepared through condensation reactions with microwave heating and characterized by elemental analysis, IR, (1)H-NMR and mass spectrometry. Geometry optimization of these compounds was executed by PM3, PM5 and Minimize Energy methods to describe them via molecular descriptors. The antimicrobial activity of the synthesized compounds was evaluated against different microbial strains using two different methods: the diffusion method and the micro-dilution method. All data indicated that the products possess antimicrobial activity which depends on the nature of substituent attached to the benzopyran moiety. In general, after 24 h the MIC values of most tested coumarins was 0.13 mg/mL, but compounds 1 and 6b displayed the strongest antimicrobial activity on the tested cultures of bacteria after 48 h. Compound 13b has the strongest growth inhibitory potential on fungus C. albicans, tested by diffusion method,with an inhibition zone of 30-37 mm at a concentration of 150 microg/mL. The conclusion of this experiment is that the synthesized compounds have varied and different influence on different classes of bacteria and the fungus C. albicans.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19384281 PMCID: PMC6254157 DOI: 10.3390/molecules14041495
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Reaction conditions, substituents and yields of obtained compounds 2b-8b.
| No | R1 | R2 | Pw (W) | Tm(S) | Ta (ºC) | Yield (%) | |
|---|---|---|---|---|---|---|---|
| A | B | ||||||
| COOEt | COOEt | 500 | 7 | 123 | 27 | 96 | |
| COMe | COOMe | 500 | 7 | 129 | 36 | 97 | |
| H | COOMe | 500 | 9 | 121 | 18 | 96 | |
| C≡N | COOMe | 500 | 7 | 121 | 33 | 94 | |
| COMe | COMe | 500 | 10 | 134 | 41 | 94 | |
| C≡N | COOH | 500 | 6 | 120 | 42 | 84 | |
| COMe | COOH | 500 | 5 | 126 | 35 | 87 | |
| Ph | 500 | 3 | 109 | 75 | 95 | ||
| p-tolyl | 500 | 3 | 109 | 73 | 97 | ||
| m-tolyl | 500 | 3 | 109 | 84 | 94 | ||
| o-tolyl | 500 | 3 | 109 | 73 | 94 | ||
| p-NO2-phenyl | 500 | 3 | 109 | 51 | 92 | ||
| m-NO2- phenyl | 500 | 3 | 109 | 62 | 97 | ||
| benzyl | 500 | 3 | 109 | 75 | 97 | ||
| C4H9COOH | 500 | 3 | 109 | 42 | 87 | ||
Molecular descriptors of observed compounds.
| Parameters | Method | Compounds | ||||||
|---|---|---|---|---|---|---|---|---|
| 1 | 3b | 4b | 6b | 7b | 8b | 13b | ||
| Heat of Formation (kcal/mol) | PM3 | -120.57 | -184.38 | -149.91 | -140.02 | -119.39 | -193.17 | -20.97 |
| PM5 | -135.31 | -207.47 | -166.62 | -168.25 | -139.00 | -214.49 | -64.73 | |
| SPARTAN(e.u) | 26.97 | 57.58 | 57.26 | 70.91 | 40.23 | 41.66 | 72.38 | |
| Electronic Energy (eV) | PM3 | -14412.18 | -26955,66 | -21039,91 | -25237,76 | -22271,14 | -25448,75 | -27320,32 |
| Core-core Repulsion (EV) | PM3 | 11811.55 | 23083.21 | 17482.15 | 21395.99 | 18547.35 | 21441.45 | 23332.61 |
| Gradient Norm | PM3 | 414.37 | 430.48 | 447.56 | 383.06 | 115.66 | 69.75 | 320.41 |
| Dipole (debye) | PM3 | 7.32 | 4.99 | 7.25 | 6.11 | 6.54 | 4.96 | 9.94 |
| SPARTAN | 3.89 | 3.85 | 5.10 | 5.76 | 5.73 | 2.79 | 8.24 | |
| Symetry | PM3 | C1 | C1 | C1 | C1 | C1 | C1 | C1 |
| SPATRAN | C1 | C1 | C1 | C1 | C1 | C1 | C1 | |
| No. of Fields Level | PM3 | 38 | 57 | 49 | 54 | 50 | 54 | 60 |
| Ionization Potencial (eV) | PM3 | 9.70 | 9.41 | 9.34 | 9.34 | 9.67 | 9.50 | 9.59 |
| Homo Lumo Energies (eV) | PM3 | -9.70 | -9.41 | -9.34 | -9.34 | -9.67 | -9.50 | -9.60 |
| -1.26 | -1.30 | -1.37 | -1.30 | -1.59 | -1.31 | -1.45 | ||
| SPARTAN | -9.39 | -9.59 | -9.54 | -9.66 | -9.75 | -9.57 | -9.81 | |
| 1.26 | -1.29 | -1.26 | -1.26 | -1.50 | -1.32 | -1.55 | ||
| Molecular Weight | PM3 | 302.28 | 260.25 | 286.28 | 271.23 | 288.26 | 342.29 | |
| Scf Calculations | PM3 | 10 | 14 | 102 | 84 | 71 | 202 | 10 |
Side chain atom angles of observed compounds.
|
| Side chain atoms | Angle (º) | Dihedral atoms | Dihedral (º) |
|---|---|---|---|---|
| 1 | -C=C-CO | 120,67 | C (enol from ring)-C=C-CO | 0,21 |
| 3b | -C=C-CO | 122,43 | -C=C-C-O | -61,94 |
| -C=C-COO | 30,95 | -C=C-C-O (carbonyl) | -3,69 | |
| -C=C-C-C (ester) | -5,48 | |||
| 4b | -C=-C(from ring)-C(Me) | 115,93 | C=C(ring)-C (side chain)-C(Me) | -127,19 |
| -C=C-CO | 126,44 | -C=C-C-O (carbonyl) | -134,44 | |
| -C=C-C-C(ester) | 47,62 | |||
| 6b | C=C-C(carbonyl) | 121,79122,84 | C=C-C-O | 88,8615,34 |
| 7b | C=C-CN | 123,06 | C=C-C-C (cyano) | 3,28 |
| C=C-C(carboxyl acid) | 122,92 | -C=C-C-O (carbonyl) | -119,99 | |
| -C=C-C-O (ester) | 61,05 | |||
| 8b | -C=C-CO | 119,79 | -C=C-C-O (carbonyl) | -54,78 |
| C=C-C(carboxyl acid) | 124,68 | -C=C-C-O (carbonyl) | 154,01 | |
| -C=C-C-O(ester) | -30,51 | |||
| 13b | =C(from ring)-C=N- | 122,79 | =C (from ring)-C=N-C (aromatic) | 180 |
Figure 1PM5 geometry of 3-acetyl-4-hydroxy-chromene-2-one (1).
Figure 2PM5 geometry of 3-(1-(4-hydroxy-2-oxo-2H-chromen-3-yl)-ethylidene)-pentane-2, 4-dione (6b).
Figure 3PM5 geometry of 4-hydroxy-3-(1-(4-nitrophenylimino)ethyl)-2H-chromen-2-one (13b).
Figure 4Spartan geometry of 4-hydroxy-3-(1-(4-nitrophenylimino)ethyl)-2H-chromen-2-one (13b).
MIC values (mg/mL) of the synthesized coumarin derivatives.
| Cultures | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| ||||||
| (isolate) | ||||||||||
| Comp. | 24 h | 48 h | 24 h | 48 h | 24 h | 48 h | 24 h | 48 h | 24 h | 48 h |
| 0.09 | 0.19 | 0.94 | 1.90 | 0.19 | 0.38 | 0.19 | 0.38 | 0.09 | 0.09 | |
| 0.13 | 0.50 | 0.50 | 1.00 | 0.13 | 0.50 | 0.13 | 0.50 | 0.13 | 0.50 | |
| 0.13 | 0.50 | 0.50 | 1.00 | 0.13 | 0.50 | 0.13 | 0.50 | 0.25 | 0.50 | |
| 0.13 | 0.25 | 0.13 | 0.50 | 0.50 | 0.50 | 0.25 | 1.00 | 0.13 | 0.25 | |
| 0.13 | 1.00 | 0.50 | 0.50 | 0.13 | 0.50 | 0.50 | 1.00 | 0.50 | 1.00 | |
| 0.13 | 0.50 | 0.50 | 1.00 | 0.13 | 0.50 | 0.13 | 0.50 | 0.13 | 0.13 | |
| 0.13 | 0.50 | 0.13 | 0.50 | 0.50 | 0.50 | 0.13 | 0.50 | 0.13 | 0.13 | |
Cylinder plate diffusion method (µg/mL) of synthesized derivatives.
| Cultures a | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | II | III | IV | V | VI | VII | |||||||||
| Time (h) | 24 | 48 | 24 | 48 | 24 | 48 | 24 | 48 | 24 | 48 | 24 | 48 | 24 | 48 | |
| Comp. | Conc.(µg/mL) | Zones of inhibition (mm) b,c,d | |||||||||||||
| 75 | 15 | 16 | 10 | 10 | 8 | 8 | 6 | 7 | 17 | 17 | 10 | 12 | 26 | 30 | |
| 75 | / | / | / | / | / | / | / | / | / | / | / | / | / | / | |
| 150 | / | / | / | / | / | / | / | / | / | / | / | / | / | / | |
| 75 | / | / | / | / | / | / | / | / | / | / | / | / | 22 | 23 | |
| 150 | / | / | / | / | / | / | / | / | / | / | / | / | 30 | 37 | |
| 75 | 12 | 13 | 15 | 16 | / | / | 7 | 8 | 16 | 16 | 8 | 10 | 20 | 25 | |
| 10 | 26 | 24 | 20 | 19 | 24 | 25 | 52 | 53 | 24 | 23 | 21 | 21 | 26 | 23 | |
a I S. aureus; II S. aureus (isolate); III M. lysodiecticus,;IV K. pneumonia; V B. subtilis, VI E. coli; VII C. albincans; b (/) means absence of an inhibition zone; the results are from experiments run in triplicate, SD=±3 mm; c ethanol solvent controls were negative; d Standards were tetracycline (10 mg/mL) and ketoconazole (10 mg/mL).
Scheme 1Reaction of Condensation of 3-acetyl-4-hydroxy-chromene-2-one (1) with carbonyl compounds 2a-8a and amines 9a-16a (A. Conventional method; B. Microwave method).